Vaxart, Inc.
VXRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $35 | $44 | $144 |
| Short-Term Investments | $26 | $5 | $50 | $23 |
| Receivables | $12 | $3 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $6 | $3 |
| Total Curr. Assets | $68 | $46 | $99 | $169 |
| Property Plant & Equip (Net) | $29 | $37 | $41 | $20 |
| Goodwill | $5 | $5 | $5 | $5 |
| Intangibles | $4 | $4 | $5 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $16 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $61 | $1 | $4 | $1 |
| Total NC Assets | $98 | $46 | $54 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $166 | $92 | $154 | $221 |
| Liabilities | – | – | – | – |
| Payables | $7 | $2 | $6 | $4 |
| Short-Term Debt | $7 | $7 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $77 | $6 | $10 | $5 |
| Total Curr. Liab. | $91 | $14 | $18 | $11 |
| LT Debt | $16 | $20 | $25 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $17 | $20 | $25 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $18 | $20 | $22 | $13 |
| Total Liabilities | $107 | $34 | $43 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$477 | -$410 | -$327 | -$219 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $535 | $467 | $438 | $407 |
| Total Equity | $59 | $58 | $111 | $188 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $166 | $92 | $154 | $221 |
| Net Debt | -$2 | -$8 | -$17 | -$119 |